ritonavir accord 100mg film-coated tablets
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - ritonavir - film-coated tablet - ritonavir 100 mg - antivirals for systemic use
highlights of prescribing information
american health packaging - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - ritonavir 100 mg - ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection. - when co-administering ritonavir with other protease inhibitors, see the full prescribing information for that protease inhibitor including contraindication information. - ritonavir is contraindicated in patients with known hypersensitivity (e.g., toxic epidermal necrolysis (ten) or stevens-johnson syndrome) to ritonavir or any of its ingredients. - ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions. - ritonavir is contraindicated with drugs that are potent cyp3a inducers where significantly reduced lopinavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance and cross-resistance. drug class drugs within class that are contraindicated with ritonavir * clinical comments alpha 1 -ad
technivie- ombitasvir and paritaprevir and ritonavir kit
abbvie inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825), ombitasvir heminonahydrate (unii: eqe3i70j3w) (ombitasvir - unii:2302768xj8), paritaprevir dihydrate (unii: hrq5901o78) (paritaprevir - unii:ou2ym37k86) - ritonavir 50 mg - technivie is indicated in combination with ribavirin for the treatment of patients with genotype 4 chronic hepatitis c virus (hcv) infection without cirrhosis or with compensated cirrhosis [see clinical studies (14)] . - the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin. - technivie is contraindicated: in patients with moderate to severe hepatic impairment (child-pugh b and c) due to risk of potential toxicity [see warnings and precautions (5.2), use in specific populations (8.6) and clinical pharmacology (12.3)] . with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events [see drug interactions (7) and clinical pharmacology (12.3)] : alpha1-adrenoreceptor antagonist: alfuzosin hcl anti-anginal: ranolazine antiarrhythmic: dronedarone anti-gout: colchicine in patients with renal and/or hepat
viekira xr- dasabuvir and ombitasvir and paritaprevir and ritonavir kit
abbvie inc. - ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825), dasabuvir sodium monohydrate (unii: og6d40m62l) (dasabuvir - unii:de54eqw8t1), paritaprevir dihydrate (unii: hrq5901o78) (paritaprevir - unii:ou2ym37k86), ombitasvir heminonahydrate (unii: eqe3i70j3w) (ombitasvir - unii:2302768xj8) - ritonavir 33.33 mg - viekira xr is indicated for the treatment of adult patients with chronic hepatitis c virus (hcv) [see dosage and administration (2.2) and clinical studies (14)] : - genotype 1b infection without cirrhosis or with compensated cirrhosis - genotype 1a infection without cirrhosis or with compensated cirrhosis for use in combination with ribavirin. - if viekira xr is administered with ribavirin, the contraindications to ribavirin also apply to this combination regimen. refer to the ribavirin prescribing information for a list of contraindications for ribavirin. - viekira xr is contraindicated: in patients with moderate to severe hepatic impairment (child-pugh b and c) due to risk of potential toxicity [see warnings and precautions (5.2), use in specific populations (8.6) and clinical pharmacology (12.3)] . with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events [see drug interactions (7) and clinical pharmac
ritonavir 100 mg film-coated tablet
accord healthcare ireland ltd. - ritonavir - film-coated tablet - 100 milligram(s) - protease inhibitors; ritonavir
lopinavir and ritonavir- lopinavir and ritonavir tablet, film coated
camber pharmaceuticals, inc. - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir and ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and pediatric patients 14 days and older. limitations of use: • genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir tablets. the number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir tablets [see microbiology (12.4)]. • lopinavir and ritonavir tablets are contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., toxic epidermal necrolysis, stevens-johnson syndrome, erythema multiforme, urticaria, angioedema) to any of its ingredients, including ritonavir. • lopinavir and ritonavir tablets are contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious an
lopinavir and ritonavir tablet, film coated
laurus labs limited - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir and ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv- 1 infection in adults and pediatric patients 14 days and older. limitations of use: - genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir. the number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir [see microbiology (12.4)] . - lopinavir and ritonavir is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., toxic epidermal necrolysis, stevens-johnson syndrome, erythema multiforme, urticaria, angioedema) to any of its ingredients, including ritonavir. - lopinavir and ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions [see drug interactions (7.1) and clinical pharmacology (12.3)] .
lopinavir and ritonavir tablet, film coated
nucare pharmaceuticals,inc. - lopinavir (unii: 2494g1jf75) (lopinavir - unii:2494g1jf75), ritonavir (unii: o3j8g9o825) (ritonavir - unii:o3j8g9o825) - lopinavir and ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv- 1 infection in adults and pediatric patients 14 days and older. limitations of use: - genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir. the number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir [ see microbiology (12.4)] . - lopinavir and ritonavir is contraindicated in patients with previously demonstrated clinically significant hypersensitivity (e.g., toxic epidermal necrolysis, stevens-johnson syndrome, erythema multiforme, urticaria, angioedema) to any of its ingredients, including ritonavir. - lopinavir and ritonavir is contraindicated with drugs that are highly dependent on cyp3a for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions [see
viekira pak-rbv paritaprevir/ritonavir/ombitasvir 75mg/50mg/12.5mg film-coated tablets and dasabuvir (as sodium salt) 250mg film
abbvie pty ltd - dasabuvir sodium monohydrate,ombitasvir,paritaprevir,ribavirin,ritonavir -
viekira pak paritaprevir/ritonavir/ombitasvir 75mg/50mg/12.5mg film-coated tablets and dasabuvir (as sodium salt) 250mg film-coa
abbvie pty ltd - dasabuvir sodium monohydrate,ombitasvir,paritaprevir,ritonavir -